Pyrazinamide drug resistance in RpsA mutant (∆438A) of Mycobacterium tuberculosis : Dynamics of essential motions and free-energy landscape analysis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pyrazinamide drug resistance in RpsA mutant (∆438A) of Mycobacterium tuberculosis
: Dynamics of essential motions and free-energy landscape analysis
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-11-03
DOI
10.1002/jcb.28013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance
- (2018) Vahid Lohrasbi et al. TUBERCULOSIS
- Alanine mutation of the catalytic sites of Pantothenate Synthetase causes distinct conformational changes in the ATP binding region
- (2018) Bharati Pandey et al. Scientific Reports
- Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains
- (2018) H. M. Adnan Hameed et al. Frontiers in Cellular and Infection Microbiology
- High throughput in silico identification and characterization of Plasmodium falciparum PRL phosphatase inhibitors
- (2017) Rajan Pandey et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Dynamics of fluoroquinolones induced resistance in DNA gyrase of Mycobacterium tuberculosis
- (2017) Bharati Pandey et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Mechanistic Principles Behind Molecular Mechanism of Rifampicin Resistance in Mutant RNA Polymerase Beta Subunit of Mycobacterium tuberculosis
- (2017) Aditi Singh et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Role of pnc A gene mutations W68R and W68G in pyrazinamide resistance
- (2017) Mansi Aggarwal et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Mechanism of Unfolding of Human Prion Protein
- (2017) Reman K. Singh et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Natural polyphenolic inhibitors against the antiapoptotic BCL-2
- (2017) Sharad Verma et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Structural insight into inhibition of REV7 protein interaction revealed by docking, molecular dynamics and MM/PBSA studies
- (2017) Xiaodong Ren et al. RSC Advances
- Molecular motions and free-energy landscape of serine proteinase K in relation to its cold-adaptation: a comparative molecular dynamics simulation study and the underlying mechanisms
- (2017) Peng Sang et al. RSC Advances
- Substrate-induced changes in dynamics and molecular motions of cuticle-degrading serine protease PL646: a molecular dynamics study
- (2017) Li-Quan Yang et al. RSC Advances
- Fragment based G-QSAR and molecular dynamics based mechanistic simulations into hydroxamic-based HDAC inhibitors against spinocerebellar ataxia
- (2016) Siddharth Sinha et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Tuberculosis
- (2016) Keertan Dheda et al. LANCET
- Prevalence and transmission of pyrazinamide resistant Mycobacterium tuberculosis in China
- (2016) Peng Xu et al. TUBERCULOSIS
- Selective binding modes and allosteric inhibitory effects of lupane triterpenes on protein tyrosine phosphatase 1B
- (2016) Tiantian Jin et al. Scientific Reports
- Tuberculosis
- (2016) Madhukar Pai et al. Nature Reviews Disease Primers
- Phenotypic and Genotypic Characterization of Pyrazinamide Resistance among Multidrug-Resistant Mycobacterium tuberculosis Isolates in Zhejiang, China
- (2015) Qiang Xia et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structural investigations of T854A mutation in EGFR and identification of novel inhibitors using structure activity relationships
- (2015) Sukriti Goyal et al. BMC GENOMICS
- Structural basis for targeting the ribosomal protein S1 ofMycobacterium tuberculosisby pyrazinamide
- (2015) Juanjuan Yang et al. MOLECULAR MICROBIOLOGY
- Computational identification of novel piperidine derivatives as potential HDM2 inhibitors designed by fragment-based QSAR, molecular docking and molecular dynamics simulations
- (2015) Aditi Singh et al. STRUCTURAL CHEMISTRY
- g_mmpbsa—A GROMACS Tool for High-Throughput MM-PBSA Calculations
- (2014) Rashmi Kumari et al. Journal of Chemical Information and Modeling
- Structural dynamic analysis of apo and ATP-bound IRAK4 kinase
- (2014) Vijayakumar Gosu et al. Scientific Reports
- Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis
- (2014) Wanliang Shi et al. Emerging Microbes & Infections
- Role of pncA and rpsA Gene Sequencing in Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates from Southern China
- (2013) Y. Tan et al. JOURNAL OF CLINICAL MICROBIOLOGY
- SwissParam: A fast force field generation tool for small organic molecules
- (2011) Vincent Zoete et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis
- (2011) W. Shi et al. SCIENCE
- Hydrophobic interactions in model enclosures from small to large length scales: non-additivity in explicit and implicit solvent models
- (2010) Lingle Wang et al. FARADAY DISCUSSIONS
- Relation between Free Energy Landscapes of Proteins and Dynamics
- (2010) Gia G. Maisuradze et al. Journal of Chemical Theory and Computation
- MolProbity: all-atom structure validation for macromolecular crystallography
- (2009) Vincent B. Chen et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Biology oftrans-Translation
- (2008) Kenneth C. Keiler Annual Review of Microbiology
- Pyrazinamide Resistance and pncA Gene Mutations in Mycobacterium tuberculosis
- (2008) P. Jureen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started